Actionable news
All posts from Actionable news
Actionable news in NVCR: NovoCure Ltd,

Novocure Enters into Employment Agreement with William Doyle

ST. HELIER, Jersey, May 11, 2016 (BUSINESS WIRE) -- Novocure NVCR, +0.08% a commercial stage oncology company pioneering a novel therapy for solid tumors, today announced that it has entered into an employment agreement with William Doyle, current Chairman and Director, to formally establish his role as Executive Chairman.

“Given our dynamic growth, we believe there is significant value in expanding Bill’s role as an executive officer at Novocure as we work together to establish Tumor Treating Fields, or TTFields, as a new treatment modality for a variety of solid tumors,” said Asaf Danziger, Chief Executive Officer. “Since his initial involvement in 2003, Bill’s leadership has been instrumental in setting the company’s strategic direction as we’ve worked together to build the immediate commercial opportunity for TTFields in glioblastoma and to develop TTFields as a potential treatment for other solid tumors.”

Mr. Doyle, as Executive Chairman, will focus on public company matters, investor relations, and, in conjunction with Mr. Danziger, on setting the strategic...